Commission Implementing Decision (EU) 2024/816 of 5 March 2024 addressing questio... (32024D0816)
Commission Implementing Decision (EU) 2024/816 of 5 March 2024 addressing questions regarding the second comparative assessment of anticoagulant rodenticide biocidal products in accordance with Article 23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council
- COMMISSION IMPLEMENTING DECISION (EU) 2024/816
- of 5 March 2024
- addressing questions regarding the second comparative assessment of anticoagulant rodenticide biocidal products in accordance with Article 23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council
- (Text with EEA relevance)
- Article 1
- Article 2
- ANNEX
- Information addressing the questions referred by all receiving competent authorities of Member States to the Commission concerning the second comparative assessment of anticoagulant rodenticide biocidal products
- (1)
- Information addressing questions related to the comparative assessment of chemical alternatives
- Question (a): Is the chemical diversity of the active substances in authorised rodenticides in the Union adequate to minimise the occurrence of resistance in the target harmful organisms?
- Question (b): For the different intended uses specified in the applications for product renewal, are alternative authorised biocidal products available?
- Question (c): Are these available non-chemical means of control and prevention methods sufficiently effective?
- Question (d): Do the alternative authorised biocidal products present no other significant economic or practical disadvantages?
- Question (e): Do the alternatives authorised biocidal products present a significantly lower overall risk for human health, animal health and the environment?
- Question (f): Would some anticoagulant active substances contained in rodenticides have a lower overall risk for human health, animal health and the environment than others.
- (2)
- Information addressing questions related to the comparative assessment of non-chemical alternatives
- Question (a): Is the chemical diversity of the active substances in authorised rodenticides in the Union adequate to minimise the occurrence of resistance in the target harmful organisms?
- Question (b): For the different intended uses specified in the applications for product renewal, are non-chemical means of control and prevention methods available?
- Question (c): Are these available non-chemical means of control and prevention methods sufficiently effective?
- Question (d): Do the non-chemical alternatives present no other significant economic or practical disadvantages?
- Question (e): Do the non-chemical alternatives present a significantly lower overall risk for human health, animal health and the environment?
- Question (f): Would some anticoagulant active substances contained in rodenticides have a lower overall risk for human health, animal health and the environment than others?
Feedback